![](/img/cover-not-exists.png)
A phase II trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancer
John J. Kavanagh, Larry J. Copeland, David M. Gershenson, Patton B. Saul, Creighton L. EdwardsVolume:
24
Year:
1986
Language:
english
DOI:
10.1016/0090-8258(86)90004-1
File:
PDF, 238 KB
english, 1986